News Update
Business Wire
Press Releases
Business Life
Legal Center
Executive Calendar
Networking Calendar
Contact Us
Media Kit

Press Releases

Medical Pharmaceuticals Headlines from PR Newswire

< Go Back

Phase 3 DECISION Trial of NEXAVAR (sorafenib) in Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Cancer Refractory to Radioactive Iodine Published in The Lancet
Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014
Microscopy Markets
General Review of Clinical Trial Environment in Japan 2014
DURECT Corporation Invites You to Join its First Quarter 2014 Earnings Conference Call
Pivotal Therapeutics announces resignation of directors
From Labial Reduction to Stem Cell G-Spot Magnification, Women are Benefitting from a New Generation of Surgery
SYLVANT™ (siltuximab) Receives FDA Approval to Treat Multicentric Castleman's Disease (MCD)
LCA-Vision Announces ISS and Glass, Lewis Recommend Stockholders Vote in Favor of $5.37 per share Cash Acquisition by PhotoMedex
Quest Diagnostics Extends Partnership with Steward Health Care System
PTC Therapeutics to Present at Upcoming Investor Conferences
Acumed® introduces new Polarus® 3 Solution to treat proximal humerus fractures
Global Vitamin D Testing Market 2014-2018
Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2014
Resmed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2014
Vermillion Appoints Chairman of Board James LaFrance as President and Chief Executive Officer
Adamas Pharmaceuticals Announces Data Update At American Academy Of Neurology Annual Meeting
NextDocs Sets Industry Standard for Scalability of Regulated Compliance Solutions
Stem Cell Therapy Market Worth $330 Million in 2020
Scripps is First in Region to Implant Wireless Cardiac Pacemaker
Neodyne Biosciences announces schedule of presentations on embrace® Advanced Scar Therapy at The Aesthetic Meeting 2014
Prostate Cancer Expert Presents PROVENGE® (sipuleucel-T) in Seal Beach, CA - an Immunotherapy Designed for Advanced Prostate Cancer
TB Alliance Grants Fosun Pharma Rights to Develop, Market Promising TB Cure in China
New Tuberculosis Drug Regimen Will Move to Landmark Phase 3 Clinical Trial
Toxic Species of Parkinson's Protein Named Focus of Funding Program
CheckIssuing joins the Pharmaceutical Marketing Research Group
Johnson & Johnson to Host Medical Devices & Diagnostics Business Review
Medical Tourism Facts and Figures 2014
Aortic Intervention Market - 2014 Edition
Lupin Appoints Theresa Stevens as Chief Corporate Development Officer
Mission Pharmacal Reaches 5-Year Milestone as National Sponsor of March for Babies®
Binimetinib Continues To Advance In Clinical Development
Next-Generation Gene Sequencing from Athena Diagnostics Streamlines Epilepsy Diagnosis
Society for Clinical Research Sites Launches the Site Advocacy Group Initiative
Genpact to Acquire Leading Regulatory Affairs Company in Life Sciences
ALPHAEON™ Launches State-of-the-Art Interactive Platform In Ophthalmology
Select Medical Holdings Corporation to Announce First Quarter 2014 Results on Thursday, May 1
Research Concludes Sugar-Sweetened Beverages Contribute to the U.S. Obesity Epidemic, Particularly Among Children
Eravacycline's Improvements in Efficacy and Delivery Over Competitors will Drive Uptake for the Treatment of Gram-Negative Infections due to Multidrug-Resistant Enterobacteriaceae
Molecular Medicine Awards 2nd Annual Ross Prize to NIH Scientist Dr. John O'Shea
Liventa Bioscience Responds To Lawsuit
MiMedx at SAWC Spring 2014: Multiple Studies And Clinical Experience Demonstrate Clinical And Cost Effectiveness Of EpiFix Allograft For Treatment Of Hard-to-Heal Wounds
ASN Announces Award Lecturers
PerceptiMed Founder Jacobs To Speak At Bio2Device Group Event
Midwest's Largest Long-Term Care Convention Held in Columbus
Lupin Inks Strategic Joint Venture Agreement with Yoshindo Inc.
Dotmatics Showcases Collaborative Project Tracking and Management Tool at Bio-IT World
WIRB-Copernicus Group's Chief Compliance Officer to Discuss Potential Impact of Corporate Consolidation on Human Research Protection Program Accreditation at 2014 AAHRPP Annual Conference
ExxonMobil Partners with Plan International to Combat Ebola Outbreak in Liberia
Two-Thirds of Americans Suffer from Allergies but Only Half See a Physician

< Prev Next >
PR Newswire - United Business Media

Search Classifieds:

Copyright © , Las Vegas Business Press